Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.06x

Beijing Sun Novo Pharmaceutical Research Co Ltd (688621) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CN¥4.69 Million (capex CN¥4.69 Million ) from operating cash flow of CN¥76.07 Million. See Beijing Sun Novo Pharmaceutical Research (688621) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.06x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥4.69 Million
Capex + Investments

Operating Cash Flow

CN¥76.07 Million
CNY

Capital Expenditures

CN¥4.69 Million
CNY

Beijing Sun Novo Pharmaceutical Research Co Ltd Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Beijing Sun Novo Pharmaceutical Research Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Beijing Sun Novo Pharmaceutical Research cash flow conversion.

Annual Cash Flow Reinvestment Rate for Beijing Sun Novo Pharmaceutical Research Co Ltd (2017–2025)

Year-by-year capital reinvestment analysis for Beijing Sun Novo Pharmaceutical Research Co Ltd. See Beijing Sun Novo Pharmaceutical Research (688621) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.22x CN¥206.80 Million CN¥93.21 Million CN¥42.43 Million ▲ +5.0%
2024 2.11x CN¥67.63 Million CN¥32.02 Million CN¥30.48 Million ▲ +21.4%
2023 1.74x CN¥161.62 Million CN¥92.86 Million CN¥72.96 Million ▲ +56.8%
2022 1.11x CN¥115.37 Million CN¥103.96 Million CN¥103.87 Million ▼ -72.9%
2021 4.09x CN¥360.74 Million CN¥88.25 Million CN¥84.96 Million ▲ +310.5%
2020 1.00x CN¥62.74 Million CN¥62.99 Million CN¥27.03 Million ▲ +39.0%
2019 0.72x CN¥40.83 Million CN¥56.97 Million CN¥25.67 Million ▲ +92.6%
2018 0.37x CN¥16.41 Million CN¥44.11 Million CN¥16.41 Million ▼ -85.8%
2017 2.62x CN¥20.96 Million CN¥8.01 Million CN¥20.96 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow